This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by David Cummings during the The Future of Bariatrics, Diabetic Care, and Metabolic Surgery: No Weight Loss Required on April 13 2018
Keyword(s): ablation, adiponectin, adipose tissue, anthropometrics, antidiabetes, bias, biomarkers, biopsy, C-reactive protein, CD4, Covidien, CRP, cytokines, dendritic cells, diabetes remission, diet, exercise, fasting glucose, flow cytometry, gastric bypass, gene expression, gene profiling, glucose homeostasis, glucose tolerance, glycemia, helper T cells, humans, IL, inflammation, insulin, insulin resistance, interleukin, J&J, Johnston & Johnston Institute, killer T cells, leukocytes, lifestyle intervention, liver, macrophages, metabolic surgery, metformin, mice, muscle, National Institutes of Health, neutrophils, NIH, obesity, OGTT, oral glucose tolerance test, Roux-en-Y gastric bypass, RYGB, sleeve gastrecomy, stromovascular cells, T cells, TNF, tumor necrosis factors, Type 2 diabetes, Type II diabetes, WAT, WBC, weight loss, white adipose tissue, white blood cell
Crossroads inflammation study–2:28 Obesity 2016
Short & longer-term inflammation study–10:29 Metabolism 2017